is this informaton all necessary>?
The overall quality of the evidence was sufficient, but limitations existed in the collected datasets responding to the claim and research question. Limited sample populations and non-repeatability appear to be common problems in the three studies, indicating relatively low reliability for the experiments conducted. For the testing process, both reliability and validity of the evidence were considered to support the effectiveness of the research question. This is a reflection of the fact that the utilisation of CRISPR-Cas9 technologies is still a fairly recent concept that has not been widely implemented in medical trials. Regarding the presentation of the graphs, Figure 3 used a biassed data collection process that excluded unwanted outcomes and only presented significant data from the whole experiment. The data did not take into account any off-gene editing that could influence the overall efficacy and safety of the gene-editing approach. Furthermore, the study did not address the long-term stability of HbF expression post-differentiation, which hinders access to therapeutic approaches. Based on the author's qualifications, the preview studies and secondary research were gathered; the scientists working on the papers all hold an M.D. or PHD related to the field of biogenetics, and so there were no issues with author credibility or biases.
1 answer